1. Home
  2. ACU vs ELTX Comparison

ACU vs ELTX Comparison

Compare ACU & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

N/A

Current Price

$40.58

Market Cap

154.0M

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.04

Market Cap

141.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
ELTX
Founded
1867
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.0M
141.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACU
ELTX
Price
$40.58
$8.04
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
8.1K
103.1K
Earning Date
10-21-2025
11-13-2025
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$194,960,991.00
N/A
Revenue This Year
$2.19
N/A
Revenue Next Year
$4.55
N/A
P/E Ratio
$16.56
N/A
Revenue Growth
2.35
N/A
52 Week Low
$34.35
$4.60
52 Week High
$45.25
$12.62

Technical Indicators

Market Signals
Indicator
ACU
ELTX
Relative Strength Index (RSI) 62.38 44.47
Support Level $40.78 $7.89
Resistance Level $42.33 $8.32
Average True Range (ATR) 1.37 0.48
MACD 0.22 0.04
Stochastic Oscillator 78.40 22.44

Price Performance

Historical Comparison
ACU
ELTX

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

Share on Social Networks: